CoChat

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

Open access
Shukla, Rameshwer, Thomas, Thommey P, Desai, Ankur M, Kotlyar, Alina, Park, Steve J, Baker Jr, James R · 2008 · Nanotechnology
Cited by 82

The DOI matches its Crossref record.

Abstract

Herceptin, a humanized monoclonal antibody that binds to human growth factor receptor-2 (HER2), was covalently attached to a fifth-generation (G5) polyamidoamine dendrimer containing the cytotoxic drug methotrexate. The specific binding and internalization of this conjugate labeled with FITC was clearly demonstrated in cell lines overexpressing HER2 by flow cytometry as well as confocal microscopic analysis. In addition, binding and uptake of antibody conjugated dendrimers was completely blocked by excess non-conjugated herceptin. The dendrimer conjugate was also shown to inhibit the dihydrofolate reductase with similar activity to methotrexate. Co-localization experiments with lysotracker red indicate that antibody conjugate, although internalized efficiently into cells, has an unusually long residence time in the lysosome. Somewhat lower cytotoxicity of the conjugate in comparison to free methotrexate was attributed to the slow release of methotrexate from the conjugate and its long retention in the lysosomal pocket.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1088/0957-4484/19/29/295102

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 82

Metadata

Authors
Shukla, R., Thomas, T. P., Desai, A. M., Kotlyar, A., Park, S. J., & Baker Jr, J. R.
Venue
Nanotechnology
Published
2008-06-10
Volume
19
Issue
29
Pages
295102
ISSN
  • 0957-4484 (ISSN-L)
  • 1361-6528
OpenAlex
W2061937882
Cited by
82
References
0
FWCI
6.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb. https://app.cochat.ai/papers/10.1088/0957-4484/19/29/295102
The paper
Shukla, R., Thomas, T. P., Desai, A. M., Kotlyar, A., Park, S. J., & Baker Jr, J. R. (2008). HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb. Nanotechnology. https://doi.org/10.1088/0957-4484/19/29/295102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.